FindTrial
Sign In

Use of antifungal drugs in very sick children admitted to Intensive Care Unit

Study of Antifungal Drug Utilization in Pediatric Intensive Care Unit of a Tertiary Care Centre - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/03/081613
Enrollment
80
Registered
2025-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B377- Candidal sepsis Health Condition 2: B448- Other forms of aspergillosis Health Condition 3: B378- Candidiasis of other sites

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients in the age group of 1 month to up to 12 years who are admitted to the PICU and treated with systemic antifungal drugs either newly started on antifungal drugs or already on antifungal drugs will be enrolled in the study

Exclusion criteria

Exclusion criteria: Patients whose parent/ guardian refuse to give informed consent, will be excluded from the study

Design outcomes

Primary

MeasureTime frame
In the patients admitted to the Pediatric intensive care unit 1 Utilization of antifungals and 2 Documentation of prescribing patterns of systemic antifungal agents Timepoint: At discharge from the PICU or at death of the patient—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactAchal Thakre

Seth G S Medical College & KEM Hospital Mumbai 400012

milindtullu@yahoo.com9869469974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026